Immunotherapy strategy could be beneficial for relapsed acute myeloid leukemia

(UNC Lineberger Comprehensive Cancer Center) UNC Lineberger Comprehensive Cancer Center researchers will present preliminary results from an ongoing phase II trial of chemotherapy and pembrolizumab in relapsed or refractory acute myeloid leukemia at the 59th American Society of Hematology Annual Meeting in Atlanta on Saturday, Dec. 9.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news